Search Results - "Blanco, Jose-Ramon"

Correction: Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy.

Authors: Blanco, Jose-Ramon Torralba, Miguel Saumoy, María et al.

Source: PLoS ONE. 7/24/2026, Vol. 21 Issue 7, p1-1. 1p.

Lack of association between loneliness, social isolation and inflammation in people living with HIV aged ≥50 years: Results from the sub-study "No One Alone-Gesida Study".

Authors: Blanco, Jose-Ramon Albendin-Iglesias, Helena Negredo-Puigmal, Eugenia et al.

Source: PLoS ONE. 12/17/2025, Vol. 20 Issue 12, p1-16. 16p.

Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naïve people living with HIV initiating integrase inhibitor-based antiretroviral therapy.

Authors: Blanco, Jose-Ramon Torralba, Miguel Saumoy, María et al.

Source: PLoS ONE. 2/18/2026, Vol. 21 Issue 2, p1-18. 18p.

The Role of Microbiota in Ovarian Cancer: Implications for Treatment Response and Therapeutic Strategies.

Authors: Blanco, Jose-Ramon del Campo, Rosa Avendaño-Ortiz, José et al.

Source: Cells (2073-4409). Nov2025, Vol. 14 Issue 22, p1813. 16p.

Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).

Authors: Blanco, Jose-Ramon Alejos, Belen Moreno, Santiago

Source: PLoS ONE. 1/16/2020, Vol. 15 Issue 1, p1-11. 11p.

Rhabdomyolysis of Infectious and Noninfectious Causes.

Authors: Blanco, Jose Ramon Zabalza, Marta Salcedo, Javier et al.

Source: Southern Medical Journal. May2002, Vol. 95 Issue 5, p542. 3p.

A note of thanks to referees for Volume 18, 2017.

Source: HIV Medicine. Nov2017, Vol. 18 Issue 10, p793-795. 3p.